search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Google’s $32B Wiz deal is just the beginning: Tel Aviv’s startup ecosystem is evolving
2
Rippling alleges ‘spy’ was paid in Deel espionage case
3
Deel and Rippling corporate espionage case takes a turn as accused ‘spy’ agrees to cooperate
4
Four Wiz founders surge up global billionaires list with $2.2B each
5
Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook
More news Buzzmore

QuantHealth

4 stories about QuantHealth
Hila Karah Pitango Health

“The long-term opportunities in AI are immense for health-tech companies”

16.01.25|James Spiro, Elihay Vidal
Hila Karah, Managing Partner at Pitango HealthTech, joined CTech to share insights in the high-tech ecosystem. 
Eran Shoni

Shoni Health Ventures outlines the landscape of opportunities and challenges in 2025

06.01.25|James Spiro, Elihay Vidal
CEO and Managing Partner Eran Lerer joined CTech to share insights on the year ahead and how HealthTech will be impacted. 
Arnon Horev Orr Inbar

QuantHealth secures $2 million in funding from Accenture and other investors to deliver AI-powered clinical trial simulations

08.01.24|CTech
This announcement extends the Israeli startup’s recent $15 million Series A and comes on the back of the launch of its latest product, Katina, which provides clinical researchers with an AI-guided workflow that simulates hundreds of thousands of potential trial protocol combinations of patient groups, treatment parameters and different endpoints, to maximize the trial success probability
Arnon Horev Orr Inbar

QuantHealth announces $15 million Series A to use AI to enhance success of clinical trials

30.08.23|CTech
The Israeli startup’s AI platform predicts efficacy and safety of clinical trials to try and optimize trial design, and identify key response population
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1